Arbutus Biopharma CorporationABUSNASDAQ
LOADING
|||
Gross Profit Over Time
Trending lower, above historical average.
Left:
|
|
|
|

Revenue minus cost of goods sold

Latest
$6.17M
↑ 130% above average
Average (9y)
$-20.83M
Historical baseline
Range
High:$39.02M
Low:$-59.80M
CAGR
NaN%
Modest growth trend
PeriodValueChange
2024$6.17M-66.0%
2023$18.14M-53.5%
2022$39.02M+255.1%
2021$10.99M+127.1%
2020$-40.57M+21.4%
2019$-51.59M+0.8%
2018$-52.00M0.0%
2017$-52.00M+13.0%
2016$-59.80M-124.5%
2015$-26.63M-